204 related articles for article (PubMed ID: 28942287)
1. The costs of crime associated with stimulant use in a Canadian setting.
Enns B; Krebs E; DeBeck K; Hayashi K; Milloy MJ; Richardson L; Wood E; Nosyk B
Drug Alcohol Depend; 2017 Nov; 180():304-310. PubMed ID: 28942287
[TBL] [Abstract][Full Text] [Related]
2. Dynamics in the costs of criminality among opioid dependent individuals.
Krebs E; Kerr T; Montaner J; Wood E; Nosyk B
Drug Alcohol Depend; 2014 Nov; 144():193-200. PubMed ID: 25282307
[TBL] [Abstract][Full Text] [Related]
3. The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California.
Krebs E; Urada D; Evans E; Huang D; Hser YI; Nosyk B
Addiction; 2017 May; 112(5):838-851. PubMed ID: 27981691
[TBL] [Abstract][Full Text] [Related]
4. Mental Distress and Use of Stimulants: Analysis of a Longitudinal Cohort of Transgender Women.
Baguso GN; Santiago-Rodriguez E; Gyamerah AO; Wilson EC; Chung C; McFarland W; Wesson P
LGBT Health; 2023 Apr; 10(3):228-236. PubMed ID: 36301245
[No Abstract] [Full Text] [Related]
5. The Stimulant Selective Severity Assessment: A replication and exploratory extension of the Cocaine Selective Severity Assessment.
Walker R; Northrup TF; Tillitski J; Bernstein I; Greer TL; Trivedi MH
Subst Use Misuse; 2019; 54(3):351-361. PubMed ID: 30657406
[TBL] [Abstract][Full Text] [Related]
6. Use of Amphetamine-Type Stimulants Among Emergency Department Patients With Untreated Opioid Use Disorder.
Chawarski MC; Hawk K; Edelman EJ; O'Connor P; Owens P; Martel S; Coupet E; Whiteside L; Tsui JI; Rothman R; Cowan E; Richardson L; Lyons MS; Fiellin DA; D'Onofrio G
Ann Emerg Med; 2020 Dec; 76(6):782-787. PubMed ID: 32782084
[TBL] [Abstract][Full Text] [Related]
7. Polysubstance Use by Stimulant Users: Health Outcomes Over Three Years.
Timko C; Han X; Woodhead E; Shelley A; Cucciare MA
J Stud Alcohol Drugs; 2018 Sep; 79(5):799-807. PubMed ID: 30422794
[TBL] [Abstract][Full Text] [Related]
8. Non-fatal stimulant overdose among homeless and unstably housed women in San Francisco, California.
Davy-Mendez T; Vittinghoff E; Dilworth SE; Suen LW; Braun C; Coffin PO; Satre DD; Riley ED
Drug Alcohol Depend; 2021 Nov; 228():109085. PubMed ID: 34600248
[TBL] [Abstract][Full Text] [Related]
9. Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report.
Palis H; MacDonald S; Jun J; Oviedo-Joekes E
Harm Reduct J; 2021 May; 18(1):57. PubMed ID: 34016137
[TBL] [Abstract][Full Text] [Related]
10. Characterizing longitudinal health state transitions among heroin, cocaine, and methamphetamine users.
Nosyk B; Li L; Evans E; Huang D; Min J; Kerr T; Brecht ML; Hser YI
Drug Alcohol Depend; 2014 Jul; 140():69-77. PubMed ID: 24837584
[TBL] [Abstract][Full Text] [Related]
11. Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women.
Smid MC; Metz TD; Gordon AJ
Clin Obstet Gynecol; 2019 Mar; 62(1):168-184. PubMed ID: 30601144
[TBL] [Abstract][Full Text] [Related]
12. Misuse of methamphetamine and prescription stimulants among youths and young adults in the community.
Wu LT; Pilowsky DJ; Schlenger WE; Galvin DM
Drug Alcohol Depend; 2007 Jul; 89(2-3):195-205. PubMed ID: 17257780
[TBL] [Abstract][Full Text] [Related]
13. Quantifying the societal cost of methamphetamine use to Australia.
Tait RJ; Whetton S; Shanahan M; Cartwright K; Ferrante A; Gray D; Kaye S; McKetin R; Pidd K; Ritter A; Roche A; Allsop S
Int J Drug Policy; 2018 Dec; 62():30-36. PubMed ID: 30352332
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
Kishi T; Matsuda Y; Iwata N; Correll CU
J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
[TBL] [Abstract][Full Text] [Related]
15. Stimulant misuse among youth.
LaBossier NJ; Hadland SE
Curr Probl Pediatr Adolesc Health Care; 2022 Sep; 52(9):101265. PubMed ID: 36184490
[TBL] [Abstract][Full Text] [Related]
16. Stimulant Use Disorders.
Park TM; Haning WF
Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):461-71. PubMed ID: 27338967
[TBL] [Abstract][Full Text] [Related]
17. Care-engaged individuals with polysubstance use in Northeastern US are undertreated for methamphetamine use disorder: a retrospective cohort study.
Yen Li M; Alba GA; Mitton J; Bearnot B
Addict Sci Clin Pract; 2021 Sep; 16(1):57. PubMed ID: 34565489
[TBL] [Abstract][Full Text] [Related]
18. Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials.
Amin-Esmaeili M; Farokhnia M; Susukida R; Leggio L; Johnson RM; Crum RM; Mojtabai R
Addiction; 2024 May; 119(5):833-843. PubMed ID: 38197836
[TBL] [Abstract][Full Text] [Related]
19. Trends in cocaine and crystal methamphetamine injection over time in a Canadian setting between 2008 and 2018.
Bach P; Ti L; Hayashi K; Cui Z; Milloy MJ; Fairbairn N
J Subst Use Addict Treat; 2023 Aug; 151():208982. PubMed ID: 36848997
[TBL] [Abstract][Full Text] [Related]
20. Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy.
Ciccarone D
Prim Care; 2011 Mar; 38(1):41-58. PubMed ID: 21356420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
